MedTrace Logo

Fecal Calprotectin Collection Protocol

NCT03143517 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2019-02-07

No results posted yet for this study

Summary

The primary objective is to obtain stool samples from subjects diagnosed with , and displaying signs and/or symptoms of IBD and/or IBS will be evaluated in this study. Eligible subjects require a diagnostic colonoscopy with possible biopsy and clinical evaluation.

Conditions

Interventions

DIAGNOSTIC_TEST

Stool collection

Stool sample collected by a subject who have been diagnosed with IBD, IBS or other GI disorder. The stool sample is tested in a laboratory where fecal calprotectin levels are quantified.

Sponsors & Collaborators

  • DiaSorin Inc.

    lead INDUSTRY

Eligibility

Min Age
4 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-19
Primary Completion
2018-08-23
Completion
2018-08-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03143517 on ClinicalTrials.gov